See also this year's filing and all EDGAR filings for this company.
PDF Report 0001517022_2022_Akebia_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001517022, Akebia Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 272,010,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 55,053,000 |
| 2 | PropertyPlantAndEquipmentNet | 6,754,000 |
| 3 | remainder_Assets | 191,733,000 |
| 4 | LiabilitiesCurrent | 256,493,000 |
| 5 | LiabilitiesNoncurrent | 137,702,000 |
| 6 | remainder_Liabilities | 54,899,000 |
| 7 | CostOfGoodsAndServicesSold | 153,394,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 174,161,000 |
| 9 | ResearchAndDevelopmentExpense | 147,852,000 |
| 10 | remainder_Expenses | 3,489,000 |
| 11 | remainder_Revenues | 213,578,000 |
| 12 | remainder_NetIncome | -17,522,000 |
| 13 | remainder_ComprehensiveNetIncome | -7,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 525,550,000 |
| 1 | Liabilities | 449,094,000 |
| 2 | Expenses | 478,896,000 |
| 3 | Revenues | 213,578,000 |
| 4 | StockholdersEquity | 76,456,000 |
| 5 | NetIncome | -282,840,000 |
| 6 | ComprehensiveNetIncome | -282,843,500 |
| 7 | BaseVar | 842,323,500 |
| 8 | EconomicCapitalRatio | -0.311 |
Edgar->Model Mapping
Feature Distribution
Change over Time
